PROM1 and colorectal cancer: CD133 is a stem cell marker that is expressed on a range of solid tumours, including hepatocellular carcinoma, glioblastoma, pancreatic cancer, gastric cancer, colorectal cancer and endothelial cells implicated in neovascularization.